摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基吗啉 | 27550-90-9

中文名称
2-甲基吗啉
中文别名
2-甲基吗啡啉
英文名称
2-methylmorpholine
英文别名
2-Methyl-morpholin;2-methyltetrahydro-1,4-oxazine
2-甲基吗啉化学式
CAS
27550-90-9
化学式
C5H11NO
mdl
MFCD08444368
分子量
101.148
InChiKey
LQMMFVPUIVBYII-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    135-136 °C
  • 密度:
    0.939 g/cm3(Temp: 25 °C)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2934999090
  • 包装等级:
    II
  • 危险类别:
    8,3
  • 危险性防范说明:
    P501,P240,P210,P233,P243,P241,P242,P264,P280,P370+P378,P303+P361+P353,P301+P330+P331,P363,P304+P340+P310,P305+P351+P338+P310,P403+P235,P405
  • 危险品运输编号:
    2734
  • 危险性描述:
    H314,H226
  • 储存条件:
    室温

SDS

SDS:afdcbf44781ce0420d1966de86a95b04
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methylmorpholine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methylmorpholine
CAS number: 27550-90-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H11NO
Molecular weight: 101.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲基吗啉 在 palladium 10% on activated carbon 、 氢气三乙胺N,N-二异丙基乙胺Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 5.5h, 生成 2-cyclopropyl-N-(4-(2-methylmorpholino)pyridin-3-yl)imidazo[1,2-b]pyridazine-8-carboxamide di(trifluoroacetate)
    参考文献:
    名称:
    [EN] GSK-3 INHIBITORS
    [FR] INHIBITEURS DE GSK-3
    摘要:
    披露通常涉及到式(I)的化合物,包括它们的盐,以及使用这些化合物治疗与GSK-3相关疾病的组合物和方法。
    公开号:
    WO2018098411A1
  • 作为产物:
    描述:
    6-methylmorpholin-3-one 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以81.3%的产率得到2-甲基吗啉
    参考文献:
    名称:
    [EN] INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING
    [FR] INHIBITEURS DE LA LIAISON PROTÉINE WDR5-PROTÉINE
    摘要:
    本申请涉及到Formula I的化合物:包括这些化合物的化合物及其用途,例如作为治疗由于抑制WDR5蛋白与其结合伙伴之间结合而介导或可治疗的疾病、疾病或症状的药物。
    公开号:
    WO2017147700A1
  • 作为试剂:
    描述:
    N-Boc-O-苄基-L-苏氨酸 在 palladium on activated charcoal 2-甲基吗啉四氮唑叔丁基过氧化氢氢气1-羟基苯并三唑N,N'-二环己基碳二亚胺三氟乙酸 作用下, 以 甲醇 为溶剂, 反应 36.0h, 生成
    参考文献:
    名称:
    Synthesis and structure of cyclic phosphopeptides containing a phosphodiester linkage
    摘要:
    The synthesis of three cyclic phosphopeptides, which contain a phosphodiester linkage, is described. Starting from either Boc-L-Ser(OBn)-OH or BOC-L-Thr(OBn)-OH, three precursors for the macro-cyclization by phosphitylation were prepared. After phosphitylation, using 4-chlorobenzyl bis(N,N-diisopropylamino)phosphinite or 4-chlorobenzyl dichlorophosphinite, subsequent oxidation and hydrogenolysis the cyclic phosphopeptides 18-20 were obtained. The solution conformation of cyclic phosphopeptide 18 was studied by NMR spectroscopy and restrained molecular dynamics calculations.
    DOI:
    10.1021/jo00066a026
点击查看最新优质反应信息

文献信息

  • [EN] 2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS 2,3-DISUBSTITUÉS DE 1-ACYL-4-AMINO-1,2,3,4-TÉTRAHYDROQUINOLÉINE ET LEUR UTILISATION COMME INHIBITEURS DE BROMODOMAINES
    申请人:GLAXOSMITHKLINE IP NO 2 LTD
    公开号:WO2014140076A1
    公开(公告)日:2014-09-18
    The present invention relates to novel compounds of formula (I), wherein R1 is C1-4alkyl; R2 is C1-4alkyl, C3-7cycloalkyl, -CH2CF3, -CH2OCH3 or heterocyclyl; R3 is C1-4alkyl, -CH2F, -CH2OH or -CH2O(O)CH3; R4 when present is as defined in claim 1; R5 when present is H, halo, hydroxy or C1-6alkoxy; A is -NH-, -O-, -S-, -SO-, -SO2-, -N(C1-4alkyl)- or -NC(O)(CH3)-; V is phenyl, heteroaromatic or pyridone any of which may be optionally substituted by 1, 2 or 3 substituents; W is CH or N; X is C or N; Y is C or N; and Z is CH or N; subject to the proviso that no more than 2 of W, X, Y and Z are N, pharmaceutical compositions containing such compounds and to their use as bromodomain inhibitors.
    本发明涉及式(I)的新化合物,其中R1为C1-4烷基;R2为C1-4烷基、C3-7环烷基、-CH2CF3、- 或杂环烷基;R3为C1-4烷基、-CH2F、- H或-CH2O(O)CH3;R4存在时如权利要求1所定义;R5存在时为H、卤素、羟基或C1-6烷氧基;A为-NH-、-O-、-S-、-SO-、-SO2-、-N(C1-4烷基)-或-NC(O)( )-;V为苯基、杂芳基或吡啶酮,其中任何一个可以选择性地被1、2或3个取代基取代;W为CH或N;X为C或N;Y为C或N;Z为CH或N;但W、X、Y和Z中不超过2个为N,含有这种化合物的药物组合物以及它们作为结构域抑制剂的用途。
  • Practical Catalytic Cleavage of C(sp <sup>3</sup> )−C(sp <sup>3</sup> ) Bonds in Amines
    作者:Wu Li、Weiping Liu、David K. Leonard、Jabor Rabeah、Kathrin Junge、Angelika Brückner、Matthias Beller
    DOI:10.1002/anie.201903019
    日期:2019.7.29
    The selective cleavage of thermodynamically stable C(sp3)−C(sp3) single bonds is rare compared to their ubiquitous formation. Herein, we describe a general methodology for such transformations using homogeneous copper‐based catalysts in the presence of air. The utility of this novel methodology is demonstrated for Cα−Cβ bond scission in >70 amines with excellent functional group tolerance. This transformation
    与它们普遍存在的形成相比,热力学稳定的C(sp 3)-C(sp 3)单键的选择性裂解是罕见的。本文中,我们描述了在空气存在下使用均相基催化剂进行此类转化的一般方法。这种新颖的方法的效用证明对C α -C β在> 70度胺具有优良的官能团耐受性键断裂。该转化建立了叔胺作为酰胺的一般合成子,并为其在例如天然产物生物活性分子中的可扩展功能化提供了宝贵的可能性。
  • 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
    申请人:Ortho Pharmaceutical Corporation
    公开号:US04826868A1
    公开(公告)日:1989-05-02
    1,5-Diaryl-3-substituted pyrazoles, a method of their preparation, compositions containing the same and methods of their use are disclosed. The pyrazoles are useful in alleviating inflammatory and cardiovascular disorders in mammals.
    1,5-二芳基-3-取代吡唑的制备方法、含有它们的组合物以及它们的使用方法被披露。这些吡唑在缓解哺乳动物的炎症和心血管疾病方面是有用的。
  • Visible‐Light‐Mediated Aerobic Oxidative C( <i>sp</i> <sup> <i>3</i> </sup> )−C( <i>sp</i> <sup> <i>3</i> </sup> ) Bond Cleavage of Morpholine Derivatives Using 4CzIPN as a Photocatalyst
    作者:Chun‐Lin Dong、Lan‐Qian Huang、Zhi Guan、Chu‐Sheng Huang、Yan‐Hong He
    DOI:10.1002/adsc.202100455
    日期:2021.8.3
    Herein, a metal-free strategy for the aerobic oxidative cleavage of the inert C(sp3)−C(sp3) bond was developed. Deconstruction of morpholine derivatives was conducted using visible light as an energy source and O2 as an oxidant under mild conditions. This procedure demonstrated suitable selectivity and functional group tolerance. Moreover, a possible mechanism involving a radical process was proposed
    在此,开发了一种用于惰性 C( sp 3 )-C( sp 3 ) 键有氧氧化裂解的无属策略。以可见光为能源,O 2为氧化剂,在温和条件下进行吗啉衍生物的解构。该程序证明了合适的选择性和官能团耐受性。此外,基于一系列机制探索和控制实验,提出了涉及激进过程的可能机制。
  • Diphenylacetylene compound, process for preparing the same and liquid
    申请人:Sumitomo Chemical Company, Limited
    公开号:US05658489A1
    公开(公告)日:1997-08-19
    A diphenylacetylene compound of the formula [1]: ##STR1## wherein R is a C.sub.1 -C.sub.12 alkyl group, a C.sub.2 -C.sub.12 alkenyl group or a C.sub.2 -C.sub.16 alkoxyalkyl group; X.sup.1, X.sup.2, X.sup.3, X.sup.4, Y.sup.1, Y.sup.2, Y.sup.3 and Y.sup.4 are independently from each other a --CH-- group, a --CF-- group or a nitrogen atom; A is a hydrogen atom, a fluorine atom, a trifluoromethyl group, a trifluoromethoxy group, a cyano group, a 4-R.sup.1 -(cycloalkyl) group, 4-R.sup.1 -(cycloalkenyl) group or a R.sup.1 --(O).sub.m group in which R.sup.1 is a C.sub.1 -C.sub.12 alkyl group, a C.sub.2 -C.sub.12 alkenyl group or a C.sub.2 -C.sub.12 alkynyl group; and m is 0 or 1, which has an excellent anisotropy of refractive index and a low viscosity and is useful as a component of a liquid crystal composition.
    一种二苯基炔化合物,其化学式为[1]: ##STR1## 其中,R为C1-C12烷基、C2-C12烯基或C2-C16氧烷基;X1、X2、X3、X4、Y1、Y2、Y3和Y4各自独立为--CH--基团、--CF--基团或氮原子;A为氢原子、原子、三甲基、三甲氧基、基、4-R1-(环烷基)基团、4-R1-(环烯基)基团或R1--(O)m基团,其中R1为C1-C12烷基、C2-C12烯基或C2-C12炔基;m为0或1,具有优异的折射率各向异性和低粘度,可用作液晶组合物的组分。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台